It promotes HCC cell proliferation, migration, and invasion via the miR-19a-3p/Rab GTPase YPT1 homolog (RAB1A) pathway, is associated with poor prognosis, and correlates positively with disease staging (Yuan et al., 2022). This evidence concerns the gene RAB1A and hepatocellular carcinoma.